Key Highlights

  • SBC Medical Group shares climbed 26.59% to USD 6.76 on Friday, November 13, 2026, per market data, after the company published third-quarter 2026 results ahead of the market open.
  • Revenue for the quarter reached USD 58.6 million from USD 43.4 million a year earlier, and Operating Income jumped 66% to USD 26.4 million, an Operating Margin of roughly 45%.
  • Profit attributable to shareholders grew 22% to USD 15.7 million, equal to USD 0.15 per basic share, while adjusted EBITDA advanced 66% to USD 27.6 million.
  • At September 30, 2026 the company held USD 198.4 million in cash, non-GAAP net cash was USD 154 million, and the clinic network reached 293 locations, with the count up 36 year over year.

Quarterly Numbers Hit Before Regular Trading

SBC Medical Group (NASDAQ:SBC) was trading up 26.59% to USD 6.76 on Friday, November 13, 2026, after the company posted its Quarterly Report ahead of the session. Sales hit USD 58.6 million, up from USD 43.4 million a year before, while Net Income attributable to the company came to USD 15.7 million compared with USD 12.8 million. On a basic per-share basis, Earnings were USD 0.15, against USD 0.12 before. The company operates as a medical services organization that supplies management support to clinics in aesthetics and other specialties, and it began trading on Nasdaq in September 2024. The screener figure is the record for the live session, and a prior close near USD 5.34 is implied (calculated).

A Soft Year-Ago Quarter Flatters the Growth Rate

Last year's third quarter was soft, with USD 43.4 million down roughly 18% from the year before, so the 35% increase starts from a depressed point. Revenue for the first nine months climbed 13% to USD 150.8 million, leaving first-half revenue near USD 92.2 million, only modestly ahead of the prior year (calculated). The quarter's operating margin near 45% and an adjusted EBITDA margin of 47% indicate how much of each sales dollar turns into profit. Net income for the nine months reached USD 37.7 million, just 2% higher, so the gain is concentrated in this quarter. No financial guidance was given and no Dividend was mentioned in the release.

Clinic Count, Patient Visits and Open Questions

SBC Medical Group (NASDAQ:SBC) grew its network to 293 clinics, while trailing twelve-month patient visits totaled 7.06 million, a 9% gain, and average spend per visit rose 4% to USD 290. Nine-month Operating Cash Flow reached USD 50.2 million. The main questions are whether the quarter's acceleration holds, given that the first half was roughly flat, and how far the Business depends on Franchise and clinic activity, particularly with no guidance offered. An Earnings Call was set for the morning of November 13, 2026. A sharp single-day rally can give back gains, and adjusted figures reported by the company do not replace GAAP results.

Where Things Stand

The move looks anchored in the quarter itself. SBC Medical Group (NASDAQ:SBC) posted revenue 35% higher at USD 58.6 million, while operating earnings rose 66% and bottom-line earnings climbed 22%, a marked improvement on a soft prior-year quarter and an uneven first half. Cash of USD 198.4 million supports the balance sheet. On the other side, nine-month profit rose just 2% and management offered no guidance. Upcoming markers are the commentary on the earnings call, the quarterly filing and whether visit and spending trends keep strengthening into the fourth quarter.